$21.9937
0.1637[0.75%]
At close: Apr 23
$21.9937
0[0.00%]
After Hours: 6:29PM EDT
Intellia Therapeutics
(NASDAQ:NTLA)Intellia Therapeutics Stock (NASDAQ:NTLA), Quotes and News Summary
Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.
| Open | $21.780 |
| Close | $21.530 |
| Volume / Avg. | 849.453K / 1.546M |
| Day Range | 21.500 - 22.850 |
| 52 Wk Range | 20.780 - 47.480 |
| Market Cap | $2.114B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 32 |
| Short Interest | 17.29% |
| Days to Cover | 13.84 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Intellia Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based ther...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intellia Therapeutics (NTLA) stock?
You can purchase shares of Intellia Therapeutics (NASDAQ: NTLA) through any online brokerage.
Who are Intellia Therapeutics's (NTLA) competitors?
Other companies in Intellia Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and TG Therapeutics (NASDAQ:TGTX).
What is the target price for Intellia Therapeutics (NTLA) stock?
The latest price target for Intellia Therapeutics (NASDAQ: NTLA) was reported by Wedbush on Tuesday, April 23, 2024. The analyst firm set a price target for 29.00 expecting NTLA to rise to within 12 months (a possible 31.86% upside). 26 analyst firms have reported ratings in the last year.
Current Stock Price for Intellia Therapeutics (NTLA)?
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $21.9937 last updated Today at April 23, 2024 at 6:29 PM EDT.
Does Intellia Therapeutics (NTLA) pay a dividend?
There are no upcoming dividends for Intellia Therapeutics.
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
Is Intellia Therapeutics (NTLA) going to split?
There is no upcoming split for Intellia Therapeutics.
What sector and industry does Intellia Therapeutics (NTLA) operate in?
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.